Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis

• KOIKE Ryuji

  Department of Pharmacovigilance, Graduate School, Tokyo Medical and Dental University

• HARIGAI Masayoshi

  Department of Pharmacovigilance, Graduate School, Tokyo Medical and Dental University

• ATSUMI Tatsuya

  Department of Medicine II, Hokkaido University Graduate School of Medicine

• AMANO Koichi

  Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University

• KAWAI Shinichi

  Division of Rheumatology, Toho University Omori Medical Center

• SAITO Kazuyoshi

  The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan

• SAITO Tomoyuki

  Department of Orthopaedic Surgery, Yokohama City University, Graduate School of Medicine

• YAMAMURA Masahiro

  Department of Rheumatology, Aichi Medical University School of Medicine

• MATSUBARA Tsukasa

  Matsubara Mayflower Hospital

• MIYASAKA Nobuyuki

  Department of Medicine and Rheumatology, Graduate School, Tokyo Medical and Dental University

Journal

• Mod Rheuamtol.

  Mod Rheuamtol. 19 (4), 351-357, 2009-08-01

Keywords

• Rheumatoid arthritis
• Tocilizumab
• Anti-TNF
• IL-6
• Antirheumatics

Details

• CRID: 1574231875596156288
• NII Article ID: 10025113303
• NII Book ID: AA1157187X
• ISSN: 14397595
• Web Site: https://search.jamas.or.jp/link/ui/2010057460
• Text Lang: en
• Data Source:
  • CiNii Articles